Adicet bio to participate in a fireside chat at the 2023 jefferies healthcare conference

Redwood city, calif. & boston--(business wire)--adicet bio, inc. (nasdaq: acet), a clinical stage biotechnology company discovering and developing allogeneic gamma delta t cell therapies for cancer, today announced that chen schor, president and chief executive officer, will participate in a fireside chat at the jefferies healthcare conference being held from june 7-9, 2023 in new york. details of the event are as follows: date: thursday, june 8, 2023 time: 10:30 a.m. et the live audio webcast.
ACET Ratings Summary
ACET Quant Ranking